Muutke küpsiste eelistusi

American Cardiovascular Pandemic: A 100-Year History [Pehme köide]

  • Formaat: Paperback / softback, 257 pages, kõrgus x laius x paksus: 229x152x13 mm, kaal: 340 g, 18 photos, appendix, glossary, notes, bibliography, index
  • Sari: McFarland Health Topics
  • Ilmumisaeg: 02-Nov-2021
  • Kirjastus: McFarland & Co Inc
  • ISBN-10: 1476685126
  • ISBN-13: 9781476685120
Teised raamatud teemal:
  • Formaat: Paperback / softback, 257 pages, kõrgus x laius x paksus: 229x152x13 mm, kaal: 340 g, 18 photos, appendix, glossary, notes, bibliography, index
  • Sari: McFarland Health Topics
  • Ilmumisaeg: 02-Nov-2021
  • Kirjastus: McFarland & Co Inc
  • ISBN-10: 1476685126
  • ISBN-13: 9781476685120
Teised raamatud teemal:
"As Americans and citizens of other industrializing countries began to enjoy lives of increasing affluence and ease during the first half of the 20th century, a rising tide of heart attacks and strokes displaced infectious diseases as the leading cause of death, killing millions in the United States and throughout the world. Although cardiovascular disease remains serious and widespread, the significant decline of per capita deaths is one of the greatest accomplishments of modern public health and medicine. Death rates from heart attack and stroke have fallen dramatically by 80% in the past 50 years -- the progress has been hard won by a combination of basic and applied laboratory research, broad and far-reaching epidemiological studies by physicians, scientists, and public health experts. Cardiovascular disease is no longer viewed as an as an inevitable feature of the natural course of aging, and complacency has given way to hope. This book focuses on developments that influenced the rise and decline ofcardiovascular mortality since 1900, but also includes insider insights from the author, a 42-year NIH employee"--
Acknowledgments vii
Preface 1(4)
1 A Gentle Pandemic?
5(8)
2 Framingham, Massachusetts
13(7)
3 Clinical Trials
20(13)
4 Lowering the Pressure
33(12)
5 Fighting Cholesterol
45(14)
6 The Tobacco Bane
59(8)
7 The Rise of Diabetes
67(13)
8 "Good" Cholesterol
80(6)
9 The Mother of All Trials
86(6)
10 Unclogging the Pipes
92(20)
11 Secondary Prevention Drugs
112(9)
12 Sudden Cardiac Arrest
121(8)
13 The Fire Within
129(4)
14 Diet, Exercise, and Obesity
133(15)
15 Racial Cardiovascular Health Disparities
148(12)
16 Wrap-Up
160(5)
Appendix: Details of Calculation of Attributable Declines in Mortality 165(8)
Glossary of Medical Terms and Acronyms 173(10)
Chapter Notes 183(32)
Bibliography 215(24)
Index 239
David Gordon is a cardiovascular epidemiologist and an internationally recognized expert on clinical trials, who recently retired after 42 years with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. He is an author or co-author of 90 peer-reviewed scholarly articles plus invited chapters in 13 medical monographs and textbooks. He lives in Chevy Chase, Maryland. Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant. For more information, visit her website at www.elaine-moore.com. She lives in Sedalia, Colorado.